Rubió Metabolomics (formerly OWL Metabolomics) is a pioneering company in metabolomics with more than 20 years of experience, at the forefront of biotechnological innovation. As part of the Rubió Group, we integrate metabolomics, proteomics, and genomics services to provide a comprehensive study of the molecular profile through biomarker identification. We also commercialize diagnostic tests for MASLD (OWLiver®) and cardiovascular risk (Liposcale®), both for clinical and research applications.
Our mission is to transform complex biological data into meaningful, easily interpretable results for clients, contributing to the advancement of research and improving patients’ lives.
Working with Rubió Metabolomics means collaborating with a multidisciplinary and experienced team specialized in metabolomics, proteomics, genomics, and Data Science. We offer tailored solutions for each project, providing clear and useful information, direct communication, adaptability, and continuous scientific guidance.
Rubió Metabolomics – Key Services
1. Metabolomics Services
Lipid profiling (UHPLC-MS): two platforms for the analysis of over 1,000 lipids
Analysis of more than 40 amino acids and derivatives, and polar metabolites (UHPLC-MS)
Quantification of bile acids and oxidized fatty acids (UHPLC-MS)
Lipoprotein and glycoprotein profiling (NMR)
2. Proteomics and Genomics Services
Targeted detection of protein biomarkers (PEA, NGS)
Genomic analysis: sequencing, diagnostics, and personalized genomics
3. Diagnostic Tests
OWLiver® – The only non-invasive test capable of detecting all harmful stages of MASLD/NASH (F0–F1, F≥2) from a single serum sample. Based on 28 biomarkers, it carries CE marking and CPT/PLA codes for commercialization in Europe and the United States.
Liposcale® – NMR-based lipoprotein profiling for cardiovascular risk assessment, enabling characterization of lipid composition, particle size, and particle number across different lipoproteins.
4. Data Science and Reporting
Data processing: multivariate and univariate analysis, predictive algorithms
Detailed reports: quantification, statistical comparisons, visualizations, and diagnostic interpretation
Rubió Metabolomics combines cutting-edge analytical platforms, expert teams, and a commitment to go beyond, generating metabolic insights that drive the success of your research.
Our Analytical Platforms
Rubió Metabolomics provides comprehensive, optimized metabolomics platforms, including UHPLC-MS services tailored to each project and experimental design.
The Expertise of Our Team
Our multidisciplinary scientific team combines deep expertise, open communication, and trust. We provide expert guidance for optimal experimental design, from sample collection to statistical interpretation.
Beyond the Conventional
We actively engage in projects, adding value by simplifying the interpretation of complex data and transforming it into actionable metabolic insights for your research.
- Pharmaceutical laboratories
- Research groups
- Biotechnology companies
- Associations
- Foundations
- Hospitals
